Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × disitamab vedotin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Stomach Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Ovarian Neoplasms 1 Muscle Invasive Bladder Cancer (MIBC) 1 Head and Neck Neoplasms 1 HER2-low Breast Cancer 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 8 Mitomycin 5 erdafitinib 4 dodecyl maltoside 4 Cystoscopy 3 Docetaxel 2 BCG Vaccine 2 pirarubicin 1 monalizumab 1 hydroxycamptothecinum 1 durvalumab 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1 Epirubicin 1 Drainage 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Accelerometry 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡